Ultragenyx Pharmaceutical
RARE
#5301
Rank
NZ$2.97 B
Marketcap
NZ$29.15
Share price
-1.17%
Change (1 day)
-49.10%
Change (1 year)

EPS for Ultragenyx Pharmaceutical (RARE)

EPS in 2026 (TTM): NZ-$9.07

According to Ultragenyx Pharmaceutical's latest financial reports the company's current EPS (TTM) is NZ-$9.41. In 2025 the company made an earnings per share (EPS) of NZ-$10.59 an increase over its 2024 EPS that were of NZ-$11.50.

EPS history for Ultragenyx Pharmaceutical from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$9.07-14.36%
2025NZ-$10.59-7.89%
2024NZ-$11.50-23.89%
2023NZ-$15.10-17.61%
2022NZ-$18.3350.67%
2021NZ-$12.17113.69%
2020NZ-$5.69-55.9%
2019NZ-$12.9182.56%
2018NZ-$7.07-45.15%
2017NZ-$12.8914.68%
2016NZ-$11.24
2014NZ-$4.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Lexicon Pharmaceuticals
LXRX
NZ-$0.25-97.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.03626-99.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ-$0.20-97.88%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ-$0.16-98.27%๐Ÿ‡บ๐Ÿ‡ธ USA